Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D10993 Tucidinostat (JAN/USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03133 Histone deacetylase inhibitor
D10993 Tucidinostat
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Other cell surface molecules
CD molecules
CD8
D10993 Tucidinostat (JAN/USAN/INN) <JP>
CD244
D10993 Tucidinostat (JAN/USAN/INN) <JP>
Enzymes
Hydrolases (EC3)
Histone deacetylase
HDAC1
D10993 Tucidinostat (JAN/USAN/INN) <JP>
HDAC2
D10993 Tucidinostat (JAN/USAN/INN) <JP>
HDAC3
D10993 Tucidinostat (JAN/USAN/INN) <JP>
HDAC10
D10993 Tucidinostat (JAN/USAN/INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10993
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10993